Compare FENC & BZAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FENC | BZAI |
|---|---|---|
| Founded | 1996 | 2010 |
| Country | United States | United States |
| Employees | N/A | 232 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.3M | 144.0M |
| IPO Year | 2010 | N/A |
| Metric | FENC | BZAI |
|---|---|---|
| Price | $7.55 | $1.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $15.00 | $7.50 |
| AVG Volume (30 Days) | 115.4K | ★ 1.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 96.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $47,538,000.00 | N/A |
| Revenue This Year | N/A | $2,317.12 |
| Revenue Next Year | $70.78 | $250.65 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 123.69 | N/A |
| 52 Week Low | $4.68 | $1.00 |
| 52 Week High | $9.92 | $6.76 |
| Indicator | FENC | BZAI |
|---|---|---|
| Relative Strength Index (RSI) | 39.52 | 37.52 |
| Support Level | $7.45 | $1.04 |
| Resistance Level | $8.27 | $1.57 |
| Average True Range (ATR) | 0.45 | 0.09 |
| MACD | -0.12 | 0.02 |
| Stochastic Oscillator | 10.51 | 28.89 |
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Blaize Holdings Inc provides a customized, programmable processor architecture suite, artificial intelligence (AI)-enabled edge computing solutions. The company is a semiconductor and software technology company dedicated to revolutionizing the world of AI.